← All organizations

Samus Therapeutics

For profitWebsite ↗

Also known as: Samus Therapeutics | Samus Therapeutics Consultant | Samus Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 15, 2022

Timeline

2010s

Jan 1, 2011
Samus Therapeutics— Founded

Drugs by trial phase (6 distinct, 10 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (15)

NCT05612633Lead sponsorPhase 2Jun 15, 2022
NCT04782609Lead sponsorPhase 1Nov 30, 2021
NCT04782609Study directorPhase 1Nov 30, 2021
NCT04505358Study directorPhase 2Jan 30, 2021
NCT04505358Lead sponsorPhase 2Jan 30, 2021
NCT04311515Study chairPhase 2Apr 24, 2020
NCT04311515Lead sponsorPhase 2Apr 24, 2020
NCT03935568Study directorPhase 1Jun 30, 2019
NCT03935568Lead sponsorPhase 1Jun 30, 2019
NCT03935555Study directorPhase 1May 1, 2019
NCT03935555Lead sponsorPhase 1May 1, 2019
NCT03373877Lead sponsorPhase 1May 24, 2018
NCT03166085CollaboratorPhase 1May 23, 2017
NCT03371420Lead sponsorEarly Phase 1Apr 30, 2016
NCT01269593CollaboratorEarly Phase 1Dec 1, 2010

Details

Founded: Boston, MA, US Jan 1, 2011
Last known activity: Jun 15, 2022